We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$4.34B
Cap. Flow %
18.68%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Consumer Discretionary 11.26%
3 Healthcare 10.95%
4 Financials 10.85%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSWC icon
1951
Capital Southwest
CSWC
$1.47B
$188K ﹤0.01%
10,577
-28,863
-73% -$531K
VOXX
1952
DELISTED
VOXX International Corporation Class A
VOXX
$187K ﹤0.01%
15,190
-1,217
-7% -$13.2K
SCHB icon
1953
Schwab US Broad Market ETF
SCHB
$43B
$187K ﹤0.01%
11,703
+10,305
+737% +$161K
KG
1954
Kestrel Group
KG
$67.1M
$186K ﹤0.01%
4,448
+1,230
+38% +$57K
XHS icon
1955
State Street SPDR S&P Health Care Services ETF
XHS
$208M
$186K ﹤0.01%
2,150
-597
-22% -$53K
INVZ icon
1956
Innoviz Technologies
INVZ
$93.2M
$186K ﹤0.01%
+53,023
New +$235K
WIA
1957
Western Asset Inflation-Linked Income Fund
WIA
$185M
$185K ﹤0.01%
21,441
VIGL
1958
DELISTED
Vigil Neuroscience
VIGL
$183K ﹤0.01%
+18,705
New +$210K
STRO icon
1959
Sutro Biopharma
STRO
$411M
$183K ﹤0.01%
+3,963
New +$251K
RDFN
1960
DELISTED
Redfin
RDFN
$183K ﹤0.01%
+20,189
New +$151K
EMLP icon
1961
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$181K ﹤0.01%
6,815
-7,113
-51% -$191K
ABOS icon
1962
Acumen Pharmaceuticals
ABOS
$157M
$180K ﹤0.01%
44,385
-8,978
-17% -$46.9K
INSE icon
1963
Inspired Entertainment
INSE
$182M
$180K ﹤0.01%
+14,035
New +$202K
BLV icon
1964
Vanguard Long-Term Bond ETF
BLV
$5.74B
$179K ﹤0.01%
+2,333
New +$176K
CORP icon
1965
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
$178K ﹤0.01%
1,852
+878
+90% +$83.6K
CAF
1966
Morgan Stanley China A Share Fund
CAF
$325M
$178K ﹤0.01%
+12,406
New +$187K
NGMS
1967
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$178K ﹤0.01%
+11,709
New +$165K
EBND icon
1968
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.27B
$178K ﹤0.01%
8,366
+3,664
+78% +$77.1K
ACRE
1969
Ares Commercial Real Estate
ACRE
$239M
$177K ﹤0.01%
19,517
-18,725
-49% -$205K
CRNX icon
1970
Crinetics Pharmaceuticals
CRNX
$8.85B
$177K ﹤0.01%
+11,035
New +$204K
MPAA icon
1971
Motorcar Parts of America
MPAA
$260M
$177K ﹤0.01%
+23,766
New +$283K
ICVT icon
1972
iShares Convertible Bond ETF
ICVT
$7.21B
$176K ﹤0.01%
+2,425
New +$176K
XITK icon
1973
State Street SPDR FactSet Innovative Technology ETF
XITK
$68.5M
$176K ﹤0.01%
1,471
-309
-17% -$35.1K
KRO icon
1974
KRONOS Worldwide
KRO
$717M
$175K ﹤0.01%
+18,971
New +$199K
BBIN icon
1975
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.64B
$175K ﹤0.01%
3,240
+1,504
+87% +$79.5K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.